Financhill
Back

Mersana Therapeutics Stock Predictions

Mersana Therapeutics Stock Forecast

  • Is Mersana Therapeutics Stock Undervalued?
    The current Mersana Therapeutics [MRSN] share price is $0.32. The Score for MRSN is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • MRSN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Mersana Therapeutics Stock Go Up Next Year?

Data Unavailable

Mersana Therapeutics Stock Rating

Data Unavailable

Mersana Therapeutics Stock Price History

Is MRSN stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MRSN is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mersana.com

52-Week Data

52-Week High:
2.88
52-Week Low:
0.26

Prediction Charts

Market Cap:
39.7M
Price in USD:
0.32
Volume:
2M
Beta:
1.66

Technical Analysis

SMA50:
0.40
SMA100:
0.71
SMA200:
1.31
52-Wk Change:
-87.06%

Stock Predictions

  • Is Mersana Therapeutics stock public?
    Yes, Mersana Therapeutics is a publicly traded company.
  • What is the Mersana Therapeutics stock quote today?
    The Mersana Therapeutics stock price is 0.32 USD today.
  • How to buy Mersana Therapeutics stock online?
    You can buy Mersana Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-22 0.33 0.38 0.38 0.33
Apr-23 0.39 0.39 0.43 0.37
Apr-24 0.39 0.36 0.39 0.36
Apr-25 0.37 0.36 0.37 0.35
Apr-28 0.36 0.38 0.39 0.36
Apr-29 0.36 0.37 0.39 0.34
Apr-30 0.36 0.43 0.44 0.35
May-1 0.43 0.40 0.43 0.38
May-2 0.41 0.40 0.41 0.38
May-5 0.39 0.37 0.39 0.36
May-6 0.36 0.32 0.36 0.31
May-7 0.33 0.32 0.34 0.31
May-8 0.32 0.34 0.34 0.32
May-9 0.33 0.32 0.35 0.31

Mersana Therapeutics Earnings

Data Unavailable

Mersana Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.02 per share, a decrease this year of $0.16 per share, and an increase next year of $0.11 per share.

* Mersana Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.